Source: Nitric Oxide. Unidades: EERP, FMRP
Subjects: ÓXIDO NÍTRICO, POLIMORFISMO, FARMACOGENÉTICA, ENDOTÉLIO VASCULAR
ABNT
OLIVEIRA-PAULA, Gustavo Henrique e LACCHINI, Riccardo e TANUS-SANTOS, José Eduardo. Clinical and pharmacogenetic impact of endothelial nitric oxide synthase polymorphisms on cardiovascular diseases. Nitric Oxide, v. 63, p. 39-51, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.niox.2016.08.004. Acesso em: 04 nov. 2024.APA
Oliveira-Paula, G. H., Lacchini, R., & Tanus-Santos, J. E. (2017). Clinical and pharmacogenetic impact of endothelial nitric oxide synthase polymorphisms on cardiovascular diseases. Nitric Oxide, 63, 39-51. doi:10.1016/j.niox.2016.08.004NLM
Oliveira-Paula GH, Lacchini R, Tanus-Santos JE. Clinical and pharmacogenetic impact of endothelial nitric oxide synthase polymorphisms on cardiovascular diseases [Internet]. Nitric Oxide. 2017 ; 63 39-51.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1016/j.niox.2016.08.004Vancouver
Oliveira-Paula GH, Lacchini R, Tanus-Santos JE. Clinical and pharmacogenetic impact of endothelial nitric oxide synthase polymorphisms on cardiovascular diseases [Internet]. Nitric Oxide. 2017 ; 63 39-51.[citado 2024 nov. 04 ] Available from: https://doi.org/10.1016/j.niox.2016.08.004